CTS vs Methode Electronics
CTS and MEI side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CTS and MEI compare
CTS is the larger company, worth 4.1 times as much as Methode Electronics ($1.7B against $422M).
CTS grew revenue faster over the last twelve months (7.6% versus 1.4% for Methode Electronics).
CTS keeps more of each dollar of sales as profit, with a net margin of 12.9% compared with −3.5% at Methode Electronics.
Both pay dividends: CTS yields 0.27% and Methode Electronics 1.7%.
CTS scores higher on the StockData Score (19 against 8 for Methode Electronics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CTS | MEI |
|---|---|---|
| Size and price | ||
| Market cap | $1.7B | $422M |
| Share price | $60.21 | $11.83 |
| Change, 1 year | 42.2% | 71.4% |
| Change, 5 years | 60.5% | −75.0% |
| Beta (5Y) | 0.97 | 1.49 |
| Employees | 3,820 | 6,650 |
| StockData Score | ||
| Total score | 19 (better) | 8 |
| Valuation score | 4 | 4 |
| Growth score | 3 (better) | 2 |
| Performance score | 5 (better) | 0 |
| Health score | 3 (better) | 1 |
| Dividend score | 4 (better) | 1 |
| Valuation | ||
| P/E | 23.8× | – |
| P/S | 3.0× | 0.4× (better) |
| P/B | 2.9× | 0.6× (better) |
| EV/EBITDA | 11.9× | 10.0× (better) |
| P/FCF | 15.8× | – |
| PEG | 4.11 | – |
| FCF yield | 6.3% (better) | −3.2% |
| Fair value | $67.01 | $25.18 |
| Margin of safety | 10.1% | 53.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 7.6% (better) | 1.4% |
| Revenue growth, 5Y average | 5.0% (better) | −1.3% |
| Net income growth (TTM) | 29.2% | – |
| EPS growth (TTM) | 33.2% | – |
| EPS growth, 5Y average | 15.6% | – |
| Profitability | ||
| Gross margin | 40.6% (better) | 19.8% |
| Operating margin | 17.0% (better) | 0.36% |
| Net margin | 12.9% (better) | −3.5% |
| FCF margin | 19.0% (better) | −1.3% |
| Return on equity | 13.0% (better) | −5.4% |
| Return on invested capital | 14.7% (better) | 0.34% |
| Financial health | ||
| Debt / equity | – | 0.47 |
| Net debt / EBITDA | – | 3.14 |
| Interest coverage | 32.9× | – |
| Current ratio | 2.59 (better) | 2.41 |
| Altman Z-score | 7.05 (better) | 2.10 |
| Piotroski F-score | 8 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 0.27% | 1.7% (better) |
| Payout ratio | 6.2% | – |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | 0.00% (better) | −12.9% |
| Buyback yield | 1.9% | – |
| Shareholder yield | 2.1% (better) | 1.7% |
| Ownership | ||
| Held by institutions | 98.9% | 95.2% |
| Held by insiders | 6.7% | 2.8% |
| Insider net buying, 12 months | −$9.8M | – |
| Short interest, % of float | 4.2% | 8.9% |
Go deeper
- CTS stock overview
- CTS income statement
- CTS valuation and score
- MEI stock overview
- MEI income statement
- MEI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.